AbstractObjective To investigate the effect of ubiquitin binding enzyme 2T (UBE2T) on the radiosensitivity of lung adenocarcinoma and unravel its possible mechanism. Methods A total of 45 patients pathologically diagnosed with different stages of lung adenocarcinoma and treated with radiotherapy in the Second Affiliated Hospital of Zunyi Medical University from March, 2019 to December, 2021 were enrolled, and the efficacy was evaluated according to response evaluation criteria in solid tumors (RECIST1.1). All patients were divided into radiosensitive group (n=25) and radioresistant group (n=20). Radiosensitive group was complete remission (CR)+partial remission (PR), and radioresistant group was stable disease (SD) + progression disease (PD). Immunohistochemistry (IHC) was used to calculate the score based on the staining intensity and the number of positive cells. Chi-square test was combined to analyze the correlation between the expression level of UBE2T in paraffin specimens of lung adenocarcinoma patients and the radiosensitivity of patients. Lentivirus UBE2T-interfered (UBE2Tsh) A549 and UBE2T-overexpressed SPC-A-1 lung adenocarcinoma cells and their respective controls were constructed for irradiation and colony formation assay. The survivor fraction curve was fitted by single-hit multi-target model. The DNA double-strand break (DSB) marker γH2AX foci were detected by immunofluorescence (IF). The expression levels of UBE2T, γH2AX and Rad51 proteins were detected by Western blot. Cell cycle and apoptosis rate of A549 were determined by flow cytometry. Binary variables were statistically analyzed by Fisher's exact probability method and measurement data were assessed by t-test. Results High-expression level of UBE2T was correlated with the radiosensitivity of lung adenocarcinoma patients (P<0.05). UBE2Tsh improved the radiosensitivity of A549 lung adenocarcinoma cells, and the sensitizing enhancement ratio (SER) was 1.795. UBE2T overexpression decreased the radiosensitivity of SPC-A-1 lung adenocarcinoma cells with an SER of 0.293. γH2AX foci number per cell were significantly increased in UBE2Tsh A549 cells after irradiation (P<0.01) . Compared with the control group, the expression level of γH2AX protein was up-regulated (P<0.01)and that of Rad51 protein was down-regulated in UBE2Tsh A549 cells after radiation (P<0.001). Compared with the control group, the expression level of γH2AX protein was down-regulated (P<0.05) and that of Rad51 protein was up-regulated in UBE2T overexpressed SPC-A-1 cells (P<0.001). The proportion of UBE2Tsh A549 cells in G2 phase was decreased (P<0.01) and cell apoptosis was increased (P<0.001). Conclusions UBE2T might promote the radioresistance of lung adenocarcinoma cells by enhancing DNA DSB repair induced by radiotherapy, inducing cell cycle G2 phase arrest, and reducing cell apoptosis.
Fund:National Natural Science Foundation of China (81760548); Science and Technology Department of Guizhou Provincial Project (ZK[2021]-452); Scientific Research Project of Guizhou Provincial Health Commission (gzwjkj2020-1-034); Zunyi Medical University Project (Dr. Startup Funds[2017]19)
Corresponding Authors:
Hu Wei, Email: huweikeyan@163.com
Cite this article:
Wu Mengjia,Wang Yunan,He Bo et al. Study on the inhibitory effect of UBE2T on radiosensitivity of lung adenocarcinoma[J]. Chinese Journal of Radiation Oncology, 2023, 32(6): 519-525.
Wu Mengjia,Wang Yunan,He Bo et al. Study on the inhibitory effect of UBE2T on radiosensitivity of lung adenocarcinoma[J]. Chinese Journal of Radiation Oncology, 2023, 32(6): 519-525.
[1] Vinod SK, Hau E. Radiotherapy treatment for lung cancer: current status and future directions[J]. Respirology, 2020,25 Suppl 2:61-71. DOI: 10.1111/resp.13870. [2] Brown S, Banfill K, Aznar MC, et al.The evolving role of radiotherapy in non-small cell lung cancer[J]. Br J Radiol, 2019,92(1104):20190524. DOI: 10.1259/bjr.20190524. [3] Diwanji TP, Mohindra P, Vyfhuis M, et al.Advances in radiotherapy techniques and delivery for non-small cell lung cancer: benefits of intensity-modulated radiation therapy, proton therapy, and stereotactic body radiation therapy[J]. Transl Lung Cancer Res, 2017,6(2):131-147. DOI: 10.21037/tlcr.2017.04.04. [4] Eberhardt WE, Stuschke M.Multimodal treatment of non-small-cell lung cancer[J]. Lancet, 2015,386(9998):1018-1020. DOI: 10.1016/S0140-6736(15)61083-2. [5] Li L, Zhu T, Gao YF, et al. Targeting DNA damage response in the radio(chemo)therapy of non-small cell lung cancer[J]. Int J Mol Sci, 2016,17(6)DOI: 10.3390/ijms17060839. [6] Kelsall IR, Langenick J, MacKay C, et al. The Fanconi anaemia components UBE2T and FANCM are functionally linked to nucleotide excision repair[J]. PLoS One, 2012,7(5):e36970. DOI: 10.1371/journal.pone.0036970. [7] Yin H, Wang XY, Zhang X, et al.UBE2T promotes radiation resistance in non-small cell lung cancer via inducing epithelial-mesenchymal transition and the ubiquitination-mediated FOXO1 degradation[J]. Cancer Lett, 2020,494:121-131. DOI: 10.1016/j.canlet.2020.06.005. [8] 王玉环, 张淑华, 穆淑坤, 等. 去泛素化酶USP33通过下调SLIT2/ROB01信号通路抑制肺腺癌的侵袭和转移[J].南方医科大学学报,2018,38(8):956-961. DOI: 10.3969/j.issn.1673-4254.2018.08.09. Wang YH, Zhang SH, Mu SK, et al.USP33 suppresses lung adenocarcinoma lung cell invasion and metastasis by down-regulating SLIT2/ROBO1 signaling pathway[J]. J South Med Univ,2018,38(8):956-961. DOI: 10.3969/j.issn.1673-4254.2018.08.09. [9] 沈惠, 欧海斌, 邵晶, 等. Myosin X对肺癌H1975细胞系放射敏感性调节及机制探讨[J].中华放射肿瘤学杂志,2021,30(9):949-955. DOI: 10.3760/cma.j.cn113030-20200209-00051. Shen H, Ou HB, Shao J, et al.Regulation and mechanism of Myosin X on radiosensitivity of non-small cell lung cancer cell line H1975 in vitro[J]. Chin J Radiat Oncol,2021,30(9):949-955. DOI: 10.3760/cma.j.cn113030-20200209-00051. [10] 游星兰, 任建敏, 毛卫波, 等. 非小细胞肺癌中PD-L1的表达及其与临床病理特征的关系[J].实用肿瘤杂志,2021,36(6):520-524. DOI: 10.13267/j.cnki.syzlzz.2021.103. You XL, Ren JM, Mao WB, et al.Expression of PD-L1 in non-small-cell lung cancer and its correlation with clinicopathological characteristics[J].J Pract Oncol,2021,36(6):520-524. DOI: 10.13267/j.cnki.syzlzz.2021.103. [11] 王东娟, 吕喜英, 林萍萍, 等. 过表达BTG2增强人肺腺癌细胞的辐射敏感性[J].中国生物化学与分子生物学报,2022,38(11):1520-1528. DOI: 10.13865/j.cnki.cjbmb.2022.09.1190. Wang DJ, Lyu XY, Lin PP, et al.The expression of BTG2 and its regulatory effect on radiosensitivity of lung adenocarcinoma[J].Chin J Biochem Mol Biol,2022,38(11):1520-1528. DOI: 10.13865/j.cnki.cjbmb.2022.09.1190. [12] Long HP, Liu JQ, Yu YY, et al.PKMYT1 as a potential target to improve the radiosensitivity of lung adenocarcinoma[J]. Front Genet, 2020,11:376. DOI: 10.3389/fgene.2020.00376. [13] 马承贤, 蔡梦娇, 韩苏夏. DNA损伤修复与肿瘤放射敏感性的研究进展[J].西安交通大学学报(医学版),2020,41(1):1-6,12. DOI: 10.7652/jdyxb202001001. Ma CX, Cai MJ, Han SX.Advances in research on DNA damage repair and tumor radiosensitivity[J].Journal of Xi'an Jiaotong University(Medical Sciences),2020,41(1):1-6,12. DOI: 10.7652/jdyxb202001001. [14] Zhang D, Tang B, Xie X, et al.The interplay between DNA repair and autophagy in cancer therapy[J]. Cancer Biol Ther, 2015,16(7):1005-1013. DOI: 10.1080/15384047.2015.1046022. [15] Rickman KA, Lach FP, Abhyankar A, et al.Deficiency of UBE2T, the E2 ubiquitin ligase necessary for FANCD2 and FANCI ubiquitination, causes FA-T subtype of fanconi anemia[J]. Cell Rep, 2015,12(1):35-41. DOI: 10.1016/j.celrep.2015.06.014. [16] Virts EL, Jankowska A, Mackay C, et al.AluY-mediated germline deletion, duplication and somatic stem cell reversion in UBE2T defines a new subtype of Fanconi anemia[J]. Hum Mol Genet, 2015,24(18):5093-5108. DOI: 10.1093/hmg/ddv227. [17] Hira A, Yoshida K, Sato K, et al.Mutations in the gene encoding the E2 conjugating enzyme UBE2T cause Fanconi anemia[J]. Am J Hum Genet, 2015,96(6):1001-1007. DOI: 10.1016/j.ajhg.2015.04.022. [18] Ueki T, Park JH, Nishidate T, et al.Ubiquitination and downregulation of BRCA1 by ubiquitin-conjugating enzyme E2T overexpression in human breast cancer cells[J]. Cancer Res, 2009,69(22):8752-8760. DOI: 10.1158/0008-5472.CAN-09-1809. [19] Ramaekers CH, van den Beucken T, Meng A, et al. Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T[J]. Radiother Oncol, 2011,101(1):190-197. DOI: 10.1016/j.radonc.2011.05.059. [20] 董隽, 王成涛, 张纯, 等. X射线诱导γH2AX焦点形成的定量分析及其致DNA双链断裂的动态变化[J].中华放射肿瘤学杂志,2018,27(3):303-308. DOI: 10.3760/cma.j.issn.1004-4221.2018.03.015. Dong J, Wang CT, Zhang C, et al.Quantitative analysis of γ-H2AX foci formation and dynamic changes in DNA double-strand breaks induced by X-ray radiation[J].Chin J Radiat Oncol,2018,27(3):303-308. DOI: 10.3760/cma.j.issn.1004-4221.2018.03.015. [21] 张孟贤, 于世英, 陈元. 宫颈癌细胞周期阻滞和凋亡与放射敏感性的关系[J].中华放射肿瘤学杂志,2002,11(2):116-117. DOI: 10.3760/j.issn:1004-4221.2002.02.019. Zhang MX, Yu SY, Chen Y. Relationship between cervical cancer cell cycle arrest and apoptosis and radiosensitivity[J].Chin J Radiat Oncol,2002,11(2):116-117. DOI: 10.3760/j.issn:1004-4221.2002.02.019. [22] 王琦琦, 曾家豫, 李强, 等. shRNA沉默Sp1对胶质瘤细胞放射敏感性的影响[J].中华放射肿瘤学杂志,2022,31(7):638-642. DOI: 10.3760/cma.j.cn113030-20210518-00196. Wang QQ, Zeng JY, Li Q, et al.Effect of shRNA silencing of Sp1 on radiosensitivity of glioma cells[J]. Chin J Radiat Oncol,2022,31(7):638-642. DOI: 10.3760/cma.j.cn113030-20210518-00196. [23] Sun JY, Zhu ZR, Li WW, et al.UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation[J]. J Exp Clin Cancer Res, 2020,39(1):222. DOI: 10.1186/s13046-020-01734-4.
2023, Vol. 32 
